ClinConnect ClinConnect Logo
Search / Trial NCT02472860

Feasibility and Effectiveness of Computerized Cognitive Training in Adolescents With Autism Spectrum Disorder

Launched by MASSACHUSETTS GENERAL HOSPITAL · Jun 11, 2015

Trial Information

Current as of June 01, 2025

Completed

Keywords

Autism Spectrum Disorder Neuroplasticity Based Cognitive Training

ClinConnect Summary

Given the limited options for treatments to improve the core symptoms of autism spectrum disorder (ASD), strategies that could target secondary features of the condition and improve quality of life for affected individuals are critical. Neuroplasticity-based cognitive training has been found to improve cognition in youth with attention deficit hyperactivity disorder (ADHD) and in adults with schizophrenia. In this trial, the investigators are seeking to extend the relevance of computerized cognitive training to youth with ASD. Given the literature, the investigators hypothesize that compute...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 ASD or previously diagnosed DSM-IV autistic disorder, Asperger's disorder or pervasive developmental disorder not otherwise specified (NOS) and who continue to manifest symptoms in core domains
  • 2. Current ASD symptomatology at time of enrollment
  • 3. Evidence of decrements in at least one of three target cognitive domains (mental flexibility/abstraction, working memory, or attention).
  • Exclusion Criteria:
  • 1. Intellectual Disability
  • 2. A known comorbid neurodevelopmental disorder with possible association with autism (i.e., fragile X syndrome, tuberous sclerosis, Angelman syndrome, Prader-Willi syndrome, Williams syndrome, neurofibromatosis, mitochondrial disorder).
  • 3. Nonverbal or minimal verbal ability
  • 4. No computer/internet connection at home
  • 5. No family member with e-mail
  • 6. Patients likely to have a change in therapeutic treatments within the next 6 weeks

About Massachusetts General Hospital

Massachusetts General Hospital (MGH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing medical research and patient care. As a prominent teaching hospital affiliated with Harvard Medical School, MGH plays a pivotal role in clinical trials across a wide range of disciplines, including cardiology, oncology, neurology, and more. The institution is dedicated to fostering innovative research that translates into effective therapies and improved health outcomes. MGH's Clinical Trials Office provides comprehensive support to facilitate the design, implementation, and management of clinical studies, ensuring adherence to the highest ethical standards and regulatory compliance. With a focus on collaboration and patient-centered care, MGH strives to enhance medical knowledge and contribute to the future of healthcare.

Locations

Patients applied

0 patients applied

Trial Officials

Alysa E Doyle, PhD

Principal Investigator

Massachusetts General Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials